Achieve Life Sciences (ACHV) Misses Q3 EPS by 9c

Achieve Life Sciences (NASDAQ: ACHV) reported Q3 EPS of ($0.36), $0.09 worse than the analyst estimate of ($0.27).

For earnings history and earnings-related data on Achieve Life Sciences (ACHV) click here.

You May Also Be Interested In

• OpenAI: after the Hugging Face incident, we committed to conducting a much broader review of actions taken by our models
• Boeing and Bell Boeing receive defense contracts totaling $56.4M
• Krait Critical Minerals closes $1.22M first tranche of placement